Ignite Creation Date:
2024-05-05 @ 5:21 PM
Last Modification Date:
2024-10-26 @ 9:31 AM
Study NCT ID:
NCT00438022
Status:
COMPLETED
Last Update Posted:
2016-10-06
First Post:
2007-02-20
Brief Title:
Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis
Sponsor:
National Institute of Allergy and Infectious Diseases NIAID
Organization:
National Institute of Allergy and Infectious Diseases NIAID
Study Overview
Official Title:
Risk Factors in Atopic Dermatitis for the Development of Eczema Herpeticum
Status:
COMPLETED
Status Verified Date:
2016-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Atopic Dermatitis AD also known as eczema is a skin disease that causes the skin to be hot dry and scaly and have severe itching There are different kinds of eczema Eczema herpeticum EH is a type of eczema that spreads due to an underlying herpes virus infection The purpose of this research study is to identify the risk factors that may cause EH
Detailed Description:
AD is characterized by chronic skin inflammation and infections It is hypothesized that AD is caused by irritants in the environment and that symptoms of EH become worse with stress and changes in hormone levels This study will examine skin cells collected from study participants to determine the risk factors for EH that are present in people with AD who develop EH
This study will examine dendritic cells DC from the skin and blood of study participants to determine the differences between DCs of study participants This study will recruit four types of participants
Group 1 will include participants with AD EH and recurrent herpes simplex virus HSV
Group 2 will include participants with AD and recurring HSV infections but without EH
Group 3 will include participants with AD but without EH or HSV infection
Group 4 will include participants in good general health without AD EH or HSV infection
At the single study visit skin and blood collection will occur
This study will examine dendritic cells DC from the skin and blood of study participants to determine the differences between DCs of study participants This study will recruit four types of participants
Group 1 will include participants with AD EH and recurrent herpes simplex virus HSV
Group 2 will include participants with AD and recurring HSV infections but without EH
Group 3 will include participants with AD but without EH or HSV infection
Group 4 will include participants in good general health without AD EH or HSV infection
At the single study visit skin and blood collection will occur
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| HHSN266200400029C | OTHER | NIH Contract | None |